A detailed history of Farther Finance Advisors, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 311 shares of VKTX stock, worth $20,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares
311
Previous 100 211.0%
Holding current value
$20,485
Previous $5.53 Million 255.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$49.84 - $70.47 $10,516 - $14,869
211 Added 211.0%
311 $19.7 Million
Q2 2024

Jul 31, 2024

BUY
$47.39 - $80.2 $3,696 - $6,255
78 Added 354.55%
100 $5.53 Million
Q1 2024

May 13, 2024

BUY
$17.4 - $94.5 $382 - $2,079
22 New
22 $1.75 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.05B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.